Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer

Authors:

Abstract
No abstract available
Funding Information
  • AstraZeneca
  • National Institutes of Health (LRP 1 L30 CA231572-01)
  • Varian Medical Systems
  • American Cancer Society (CSDG-CCE 133738)
  • Janssen Pharmaceutica
  • Bayer Fund
  • ViewRay
  • Astellas Pharma US

This publication has 63 references indexed in Scilit: